Insider Stock Trading History of Doogan Declan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Doogan Declan since year 2005. The trader's CIK number is 1704234. At the time of this reporting, Doogan Declan is the Director of Biohaven Pharmaceutical Holding Co Ltd. . (stock ticker symbol BHVN). See this page for all insider trading activities at Biohaven Pharmaceutical Holding Co Ltd. .


Stock purchases, sales, and option exercises reported by insider Doogan Declan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-04 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 39,453 35.05 1,382,827
2018-06-05 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 49,763 35.70 1,776,787
2018-06-01 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 83,898 35.04 2,939,785
2018-05-30 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 842 35.00 29,470
2018-05-31 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 26,044 35.01 911,800
2018-01-16 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 38,867 26.83 1,042,801
2018-01-17 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 61,256 26.52 1,624,202
2018-01-18 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 27,935 28.13 785,727
2018-01-10 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 40,362 28.69 1,157,985
2018-01-11 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 48,138 26.52 1,276,619
2018-01-12 BHVN Biohaven Pharmaceutical Holding Co Ltd. Sale 33,442 26.36 881,531

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doogan Declan (Director of Biohaven Pharmaceutical Holding Co Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.